Showing 1 - 9 results of 9 for search 'Haohao Lu', query time: 0.04s Refine Results
  1. 1
    Efficacy and safety of tyrosine kinase inhibitors plus PD-1 inhibitor in patients with transarterial chemoembolization- refractory hepatocellular carcinoma: a two-center retrospective study

    Efficacy and safety of tyrosine kinase inhibitors plus PD-1 inhibitor in patients with transarterial chemoembolization- refractory hepatocellular carcinoma: a two-center retrospect... by Ya Gao, Haohao Lu, Zhifan Xiong

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study

    Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study by Haohao Lu, Bin Liang, Xiangwen Xia, Chuansheng Zheng

    Published 2023-10-01
    Get full text
    Article
  3. 3
    Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma

    Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma by Haohao Lu, Bin Liang, Chuansheng Zheng, Xiangwen Xia

    Published 2024-11-01
    Get full text
    Article
  4. 4
    Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinoma

    Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinoma by Haohao Lu, Bin Liang, Xiangwen Xia, Chuansheng Zheng

    Published 2024-09-01
    Get full text
    Article
  5. 5
    TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma

    TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma by Haohao Lu, Chuansheng Zheng, Bin Xiong, Xiangwen Xia

    Published 2023-03-01
    Get full text
    Article
  6. 6
    Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study

    Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study by Haohao Lu, Haohao Lu, Chuansheng Zheng, Chuansheng Zheng, Bin Liang, Bin Liang, Xiangwen Xia, Xiangwen Xia, Hongjie Fan, Hongjie Fan

    Published 2024-01-01
    Get full text
    Article
  7. 7
    Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study

    Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study by Haohao Lu, Qing Ye, Chuansheng Zheng, Li Fan, Xiangwen Xia

    Published 2023-03-01
    Get full text
    Article
  8. 8
    A nomogram based on quantitative MR signal intensity predicts early response to combined systemic treatment in patients with hepatocellular carcinoma

    A nomogram based on quantitative MR signal intensity predicts early response to combined systemic treatment in patients with hepatocellular carcinoma by Ran Tao, Haohao Lu, Xiangjun Dong, Qian Qian Ren, Hongjie Fan, Zhaoming Tang, Xiangwen Xia

    Published 2025-03-01
    Get full text
    Article
  9. 9
    First Detection of a Novel Posavirus 2 Strain Identified from Pigs in China

    First Detection of a Novel Posavirus 2 Strain Identified from Pigs in China by Li Chen, Haohao Lu, Xue Gao, Han Zhou, Jinghao Wang, Zhidong Zhang, Bin Chen, Chun Li, Luqi Liang, Long Zhou, Yi Zhang

    Published 2024-11-01
    Get full text
    Article

Search Tools: